Renal Cancer - Results from #560

Genomic Fabrics of the Excretory System's Functional Pathways Remodeled in Clear Cell Renal Cell Carcinoma. January 5, 2024

Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors. January 5, 2024

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial. January 5, 2024

Discontinuation of Immune-oncology Combinations due to Immune-related Adverse Events in Patients With Advanced Renal Cancers. January 4, 2024

Integration of bioinformatics analysis to identify possible hub genes and important pathways associated with clear cell renal cell carcinoma. January 4, 2024

Preserving Renal Function without Compromising Oncological Outcomes: A Comparative Study of Partial and Total Nephrectomies in T3 Stage Renal Cell Carcinoma. January 3, 2024

Papillary Renal Cell Carcinoma: Demographics, Survival Analysis, Racial Disparities, and Genomic Landscape. January 3, 2024

Comparison of aggressiveness in central versus peripheral T1a clear-cell renal cell carcinoma. January 2, 2024

Percutaneous cryoablation of 100 anterior renal tumors: safety and technical success. January 2, 2024

Mesenchymal-Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis. January 1, 2024

Associations between R.E.N.A.L. nephrometry score and survival outcomes in renal tumours. January 1, 2024

Treatment Landscape of Renal Cell Carcinoma. December 29, 2023

Short- and Long-Term Renal Function After Partial Nephrectomy: Comparison of Solitary and Multifocal Renal Masses. December 29, 2023

Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma. December 28, 2023

Functional recovery after partial nephrectomy in a solitary kidney. December 28, 2023

Early Evolution in Cancer: A Mathematical Support for Pathological and Genomic Evidence in Clear Cell Renal Cell Carcinoma. December 27, 2023

Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma. December 27, 2023

Correlation between bilateral GFR in patients with localized renal cancer after partial nephrectomy. December 26, 2023

Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma. December 26, 2023

Genomic Evolution of Oligometastatic Clear Cell Renal Cell Carcinoma Presenting Two Decades Following Radical Nephrectomy. December 25, 2023

Page 29 of 456